The 90th Edition HDA Factbook (2019–2020) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.

PRICE : $0.00 - $0.00

Published in collaboration with Deloitte Consulting LLP, The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation...

PRICE : $0.00 - $0.00

The 11th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceuticals offers insight into this unique marketplace, and closely examines specialty distribution measures...

PRICE : $0.00 - $0.00

The fourth edition of this survey provides unbiased, objective data on the current readiness of manufacturers and distributors to meet DSCSA’s requirements.

PRICE : $0.00 - $0.00

This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013.

PRICE : $0.00 - $0.00

Since 1992, the 340B Drug Pricing Program has played a modest, but increasingly important, role in the U.S. healthcare market.

PRICE : $0.00 - $0.00

Product returns are inevitable. Annually, more than 120 million product units — exceeding $13 billion in value — move through the reverse distribution process.

PRICE : $0.00 - $0.00

This whitepaper provides an analysis of the current market for biosimilars in the U.S. through interviews conducted with senior executives from specialty pharmaceutical manufacturing and distribution companies.

PRICE : $0.00 - $0.00

This turnkey presentation for manufacturer, distributor and pharmacy presenters/trainers includes an explanation of the pharmaceutical supply chain players and a discussion on the economics of distribution.

PRICE : $0.00 - $0.00

This turnkey presentation includes an explanation of the specialty pharmaceutical supply chain players and a discussion on the economics of specialty pharmaceutical distribution.

PRICE : $0.00 - $0.00